Search research articles
Contact Us
Filters
Showing results (121-130 of 184) with videos related to
Page
of 19
Sort By:
Frontiers in Bioscience (Landmark Edition)
|
April 29, 2026
Discovering the Hidden Power of NGLY1: Orchestrating Immune Cell Functions and Autoimmune Diseases
Christina B Brunner, Melissa C Schubbert, Maximilian M Siewert, et al.
Journal of the American Academy of Dermatology
|
August 23, 2000
Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients
M H Schmid-Wendtner, B Brunner, B Konz, et al.
Hefte Zur Unfallheilkunde
|
January 1, 1975
[Results of Bandi's antepositioning surgery of the tibial tuberosity]
B Brunner, C Burri, P Freiburghaus, et al.
European Journal of Clinical Pharmacology
|
January 1, 1984
A potent converting enzyme inhibitor CGS 13928C. Drug profile in normal volunteers
M D Schaller, D B Brunner, J Nussberger, et al.
Oncogene
|
May 2, 2007
Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1
N Cordes, S Frick, T B Brunner, et al.
Cancer Biology & Therapy
|
July 25, 2012
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy
Remko Prevo, Emmanouil Fokas, Philip M Reaper, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers
J Nussberger, T Fasanella d'Amore, M Porchet, et al.
Veterinary Clinical Pathology
|
September 20, 2024
What is your diagnosis? Mammary mass in a female dog
Gabrielle Z Tres, Igor R Santos, Milena C Paz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 25, 2020
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro
A Allam Mohamed, Andreas Thomsen, Marie Follo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2008
Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
Thomas B Brunner, Matthias Geiger, Gerhard G Grabenbauer, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 184) with videos related to
Sort By:
Page
of 19
Frontiers in Bioscience (Landmark Edition)
|
April 29, 2026
Discovering the Hidden Power of NGLY1: Orchestrating Immune Cell Functions and Autoimmune Diseases
Christina B Brunner, Melissa C Schubbert, Maximilian M Siewert, et al.
Journal of the American Academy of Dermatology
|
August 23, 2000
Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients
M H Schmid-Wendtner, B Brunner, B Konz, et al.
Hefte Zur Unfallheilkunde
|
January 1, 1975
[Results of Bandi's antepositioning surgery of the tibial tuberosity]
B Brunner, C Burri, P Freiburghaus, et al.
European Journal of Clinical Pharmacology
|
January 1, 1984
A potent converting enzyme inhibitor CGS 13928C. Drug profile in normal volunteers
M D Schaller, D B Brunner, J Nussberger, et al.
Oncogene
|
May 2, 2007
Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1
N Cordes, S Frick, T B Brunner, et al.
Cancer Biology & Therapy
|
July 25, 2012
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy
Remko Prevo, Emmanouil Fokas, Philip M Reaper, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers
J Nussberger, T Fasanella d'Amore, M Porchet, et al.
Veterinary Clinical Pathology
|
September 20, 2024
What is your diagnosis? Mammary mass in a female dog
Gabrielle Z Tres, Igor R Santos, Milena C Paz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 25, 2020
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro
A Allam Mohamed, Andreas Thomsen, Marie Follo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2008
Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
Thomas B Brunner, Matthias Geiger, Gerhard G Grabenbauer, et al.
Page
of 19